<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8449904" created="31/10/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8449904</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="transcriptional_regulation" sem="Other">Transcriptional regulation</term> of the <term id="T2" lex="pyruvate_kinase_erythroid-specific_promoter" sem="DNA_domain_or_region">pyruvate kinase erythroid-specific promoter</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Regulation"/>
<theme idref="T2"/>
<clue><clueType>Transcriptional regulation</clueType> <linkTheme>of</linkTheme> the pyruvate kinase erythroid-specific promoter.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T3" lex="mammal_pyruvate_kinases" sem="Protein_family_or_group">Mammal pyruvate kinases</term> are encoded by two genes.</sentence>
<sentence id="S3">The <term id="T4" lex="L_gene" sem="DNA_domain_or_region">L gene</term> produces the <term id="T5" lex="erythroid_isozyme" sem="Protein_molecule">erythroid</term> (<term id="T6" lex="R-PK" sem="Protein_molecule">R-PK</term>) or the <term id="T7" lex="hepatic_(L-PK)_isozyme" sem="Protein_molecule">hepatic (<term id="T8" lex="L-PK" sem="Protein_molecule">L-PK</term>) isozymes</term> by the alternative use of two <term id="T9" lex="promoter" sem="DNA_domain_or_region">promoters</term>.</sentence>
<event KT="Other" id="E2">
<type class="Gene_expression"/>
<theme idref="T6"/>
<clue>The L gene <clueType>produces</clueType> the erythroid (R-PK) or the hepatic (L-PK) isozymes by the alternative use of two promoters.</clue>
</event>
<event KT="Other" id="E3">
<type class="Gene_expression"/>
<theme idref="T8"/>
<clue>The L gene <clueType>produces</clueType> the erythroid (R-PK) or the hepatic (L-PK) isozymes by the alternative use of two promoters.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T9"/>
<clue>The L gene produces the erythroid (R-PK) or the hepatic (L-PK) isozymes <linkCause>by the alternative use of</linkCause> two promoters.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Fact" id="E5">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T9"/>
<clue>The L gene produces the erythroid (R-PK) or the hepatic (L-PK) isozymes <linkCause>by the alternative use of</linkCause> two promoters.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S4">We report the characterization of the <cons id="T10" lex="(AND cis-acting_element trans-acting_element)" sem="(AND DNA_domain_or_region DNA_domain_or_region)"><frag id="F1"><term id="A1" sem="DNA_domain_or_region">cis-</term></frag> and <frag id="F2"><term id="A2" sem="DNA_domain_or_region">trans-</term></frag><frag id="F3"><term id="A3" sem="DNA_domain_or_region">acting elements</term></frag></cons> involved in the tissue-specific activity of the <term id="T11" lex="L_gene_erythroid_promoter" sem="DNA_domain_or_region">L gene erythroid promoter</term>.</sentence>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<clue>We report the characterization of the cis- and trans-acting elements involved in the <clueLoc>tissue-specific</clueLoc> <clueType>activity</clueType> <linkTheme>of</linkTheme> the L gene erythroid promoter.</clue>
</event>
<event KT="Analysis" id="E7">
<type class="Correlation"/>
<theme idref="E6"/>
<theme idref="A1" idref1="A3"/>
<clue>We <clueKT>report</clueKT> the <clueKT>characterization</clueKT> of the cis- and trans-acting elements <clueType>involved</clueType> <linkTheme>in</linkTheme> the tissue-specific activity of the L gene erythroid promoter.</clue>
</event>
<event KT="Analysis" id="E8">
<type class="Correlation"/>
<theme idref="E6"/>
<theme idref="A2" idref1="A3"/>
<clue>We <clueKT>report</clueKT> the <clueKT>characterization</clueKT> of the cis- and trans-acting elements <clueType>involved</clueType> <linkTheme>in</linkTheme> the tissue-specific activity of the L gene erythroid promoter.</clue>
</event>
<sentence id="S5">A <term id="T12" lex="R-PK_DNA_fragment" sem="DNA_molecule">R-PK DNA fragment</term> extending from -870 to +54 relative to the <term id="T13" lex="cap_site" sem="DNA_domain_or_region">cap site</term> confers <term id="A5" sem="Cell_natural">erythroid</term> specificity to a <term id="T14" lex="reporter_gene" sem="DNA_family_or_group">reporter gene</term>.</sentence>
<event id="E9">
<type class="Positive_regulation"/>
<theme idref="T14"/>
<clue>A R-PK DNA fragment extending from -870 to +54 relative to the cap site confers <clueLoc>erythroid</clueLoc> <clueType>specificity</clueType> <linkTheme>to</linkTheme> a reporter gene.</clue>
</event>
<event id="E10">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="T12"/>
<clue>A R-PK DNA fragment extending from -870 to +54 relative to the cap site <clueType>confers</clueType> erythroid specificity to a reporter gene.</clue>
</event>
<sentence id="S6">Within this region, we define a <term id="T15" lex="minimal_promoter" sem="DNA_domain_or_region">minimal promoter</term> (-62 to +54) that displays <term id="T16" lex="erythroid-specific_activity" sem="Other"><term id="A6" sem="Cell_natural">erythroid</term>-specific activity</term> and contains two <term id="A7" sem="DNA_domain_or_region">DNA binding sites</term>.</sentence>
<event KT="Analysis" id="E11">
<type class="Positive_regulation"/>
<theme idref="T15"/>
<clue>Within this region, we <clueKT>define</clueKT> a minimal promoter (-62 to +54) that <clueType><clueKT>displays</clueKT></clueType> <clueLoc>erythroid-specific</clueLoc> <clueType>activity</clueType> and contains two DNA binding sites.</clue>
</event>
<sentence id="S7">One, located at -50, binds members of the <term id="T17" lex="CCACC/Sp1_family" sem="Protein_family_or_group">CCACC/Sp1 family</term> and the other, located at -20, binds the <term id="T18" lex="erythroid_factor_GATA-1" sem="Protein_molecule">erythroid factor GATA-1</term>.</sentence>
<event id="E12">
<type class="Binding"/>
<theme idref="T15"/>
<theme idref="T17"/>
<clue><corefTheme>One, located at -50</corefTheme>, <clueType>binds</clueType> members of the CCACC/Sp1 family and the other, located at -20, binds the erythroid factor GATA-1.</clue>
</event>
<event id="E13">
<type class="Binding"/>
<theme idref="T15"/>
<theme idref="T18"/>
<clue>One, located at -50, binds members of the CCACC/Sp1 family and <corefTheme>the other, located at -20</corefTheme>, <clueType>binds</clueType> the erythroid factor GATA-1.</clue>
</event>
<sentence id="S8">Although the -20 <term id="T19" lex="GATA_binding_site" sem="DNA_domain_or_region">GATA binding site</term> (<term id="T20" lex="AGATAA" sem="Polynucleotide">AGATAA</term>) is also a potential <term id="T21" lex="TFIID_binding_site" sem="DNA_domain_or_region">TFIID binding site</term>, it does not bind <term id="T22" lex="TFIID" sem="Protein_molecule">TFIID</term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E14">
<type class="Binding"/>
<theme idref="T19"/>
<theme idref="T22"/>
<clue>Although the -20 GATA binding site (AGATAA) is also a potential TFIID binding site, <corefTheme>it</corefTheme> does <cluePolarity>not</cluePolarity> <clueType>bind</clueType> TFIID.</clue>
</event>
<sentence id="S9">Furthermore, the substitution of this <term id="T23" lex="GATA_binding_site" sem="DNA_domain_or_region">GATA binding site</term> by a canonical <term id="T24" lex="TFIID_binding_site" sem="DNA_domain_or_region"><term id="T25" lex="TFIID" sem="Protein_molecule">TFIID</term> binding site</term> suppresses the promoter activity.</sentence>
<event KT="Method" id="E15">
<type class="Artificial_process"/>
<theme idref="T23"/>
<theme idref="T24"/>
<clue>Furthermore, the <clueType>substitution</clueType> <linkTheme>of</linkTheme> this GATA binding site <linkTheme>by</linkTheme> a canonical TFIID binding site suppresses the promoter activity.</clue>
</event>
<event id="E16">
<type class="Negative_regulation"/>
<theme idref="T15"/>
<cause idref="E15"/>
<clue>Furthermore, the substitution of this GATA binding site by a canonical TFIID binding site <clueType>suppresses</clueType> the promoter activity.</clue>
</event>
<sentence id="S10">Mutations and deletions of both sites indicate that only the association of <term id="T26" lex="CCACC/Sp1" sem="DNA_domain_or_region">CCACC/Sp1</term> and <term id="T27" lex="GATA_binding_site" sem="DNA_domain_or_region">GATA binding</term> <term id="A34" sem="DNA_domain_or_region">sites</term> can drive efficient and tissue-specific expression of this <term id="T29" lex="minimal_promoter" sem="DNA_domain_or_region"><term id="T28" lex="R-PK" sem="Protein_molecule">R-PK</term> minimal promoter</term>.</sentence>
<event KT="Analysis" id="E17">
<type class="Binding"/>
<theme idref="T26" idref1="A34"/>
<clue>Mutations and deletions of both sites indicate that only the <clueType><clueKT>association</clueKT></clueType> <linkTheme>of</linkTheme> CCACC/Sp1 and GATA binding sites can drive efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
<comment>NER T26, T27, T29 MOD, OKAP &quot;another THEME is not mentioned&quot;</comment></event>
<event KT="Analysis" id="E117">
<type class="Binding"/>
<theme idref="T27" idref1="A34"/>
<clue>Mutations and deletions of both sites indicate that only the <clueType><clueKT>association</clueKT></clueType> <linkTheme>of</linkTheme> CCACC/Sp1 and GATA binding sites can drive efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
<comment>OKAP &quot;another THEME is not mentioned&quot;</comment></event>
<event KT="Other" id="E18">
<type class="Gene_expression"/>
<theme idref="T29"/>
<clue>Mutations and deletions of both sites indicate that only the association of CCACC/Sp1 and GATA binding sites can drive efficient and <clueLoc>tissue-specific</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> this R-PK minimal promoter.</clue>
</event>
<event CL="L2" KT="Analysis" id="E19">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="E17"/>
<clue><clueExperiment>Mutations and deletions of both sites</clueExperiment> <clueKT>indicate</clueKT> that only the association of CCACC/Sp1 and GATA binding sites <clueCL>can</clueCL> <clueType>drive</clueType> efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
</event>
<event CL="L2" KT="Analysis" id="E119">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="E117"/>
<clue><clueExperiment>Mutations and deletions of both sites</clueExperiment> <clueKT>indicate</clueKT> that only the association of CCACC/Sp1 and GATA binding sites <clueCL>can</clueCL> <clueType>drive</clueType> efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
</event>
<event id="E219">
<type class="Mutagenesis"/>
<theme idref="T26" idref1="A34"/>
<clue><clueType>Mutations</clueType> and deletions <linkTheme>of</linkTheme> <corefTheme>both sites</corefTheme> indicate that only the association of CCACC/Sp1 and GATA binding sites can drive efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
</event>
<event id="E120">
<type class="Mutagenesis"/>
<theme idref="T27" idref1="A34"/>
<clue><clueType>Mutations</clueType> and deletions <linkTheme>of</linkTheme> <corefTheme>both sites</corefTheme> indicate that only the association of CCACC/Sp1 and GATA binding sites can drive efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
</event>
<event KT="Method" id="E121">
<type class="Negative_regulation"/>
<theme idref="T26" idref1="A34"/>
<clue>Mutations and <clueType>deletions</clueType> <linkTheme>of</linkTheme> <corefTheme>both sites</corefTheme> indicate that only the association of CCACC/Sp1 and GATA binding sites can drive efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Method" id="E122">
<type class="Negative_regulation"/>
<theme idref="T27" idref1="A34"/>
<clue>Mutations and <clueType>deletions</clueType> <linkTheme>of</linkTheme> <corefTheme>both sites</corefTheme> indicate that only the association of CCACC/Sp1 and GATA binding sites can drive efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
<comment>ARTIFICIAL</comment></event>
<sentence id="S11">Finally, by <term id="T30" lex="co-transfection_experiment" sem="Other">co-transfection experiments</term>, we study the <term id="T34" sem="DNA_domain_or_region">elements</term> involved in the <term id="T31" lex="hGATA-1_transactivation" sem="Other"><term id="A10" sem="Protein_molecule">hGATA-1</term> transactivation</term> of the <term id="T32" lex="R-PK_promoter" sem="DNA_domain_or_region">R-PK promoter</term> in <term id="T33" lex="HeLa_cells" sem="Cell_cultured">HeLa cells</term>.</sentence>
<event KT="Other" id="E20">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<cause idref="A10"/>
<clue>Finally, by co-transfection experiments, we study the elements involved in the hGATA-1 <clueType>transactivation</clueType> <linkTheme>of</linkTheme> the R-PK promoter in HeLa cells.</clue>
</event>
<event KT="Investigation" id="E21">
<type class="Correlation"/>
<theme idref="T34"/>
<theme idref="E20"/>
<clue>Finally, <clueExperiment>by co-transfection experiments</clueExperiment>, we <clueKT>study</clueKT> the elements <clueType>involved</clueType> <linkTheme>in</linkTheme> the hGATA-1 transactivation of the R-PK promoter <clueLoc>in HeLa cells</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
